Literature DB >> 34415199

Minimizing table time in patients with claustrophobia using focused ferumoxytol-enhanced MR angiography (f-FEMRA): a feasibility study.

Puja Shahrouki1, Kim-Lien Nguyen1, John M Moriarty1, Adam N Plotnik1, Takegawa Yoshida1, J Paul Finn1.   

Abstract

OBJECTIVES: To assess the feasibility of a rapid, focused ferumoxytol-enhanced MR angiography (f-FEMRA) protocol in patients with claustrophobia.
METHODS: In this retrospective study, 13 patients with claustrophobia expressed reluctance to undergo conventional MR angiography, but agreed to a trial of up to 10 min in the scanner bore and underwent f-FEMRA. Thirteen matched control patients who underwent gadolinium-enhanced MR angiography (GEMRA) were identified for comparison of diagnostic image quality. For f-FEMRA, the time from localizer image acquisition to completion of the angiographic acquisition was measured. Two radiologists independently scored images on both f-FEMRA and GEMRA for arterial and venous image quality, motion artefact and diagnostic confidence using a 5-point scale, five being best. Signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) in the aorta and IVC were measured. The Wilcoxon rank-sum test, one-way ANOVA with Tukey correction and two-tailed t tests were utilized for statistical analyses.
RESULTS: All scans were diagnostic and assessed with high confidence (scores ≥ 4). Average scan time for f-FEMRA was 6.27 min (range 3.56 to 10.12 min), with no significant difference between f-FEMRA and GEMRA in diagnostic confidence (4.86 ± 0.24 vs 4.69 ± 0.25, p = 0.13), arterial image quality (4.62 ± 0.57 vs 4.65 ± 0.49, p = 0.78) and motion artefact score (4.58 ± 0.49 vs 4.58 ± 0.28, p > 0.99). f-FEMRA scored significantly better for venous image quality than GEMRA (4.62 ± 0.42 vs 4.19 ± 0.56, p = 0.04). CNR in the IVC was significantly higher for steady-state f-FEMRA than GEMRA regardless of the enhancement phase (p < 0.05).
CONCLUSIONS: Comprehensive vascular MR imaging of the thorax, abdomen and pelvis can be completed in as little as 5 min within the magnet bore using f-FEMRA, facilitating acceptance by patients with claustrophobia and streamlining workflow. ADVANCES IN KNOWLEDGE: A focused approach to vascular imaging with ferumoxytol can be performed in patients with claustrophobia, limiting time in the magnet bore to 10 min or less, while acquiring fully diagnostic images of the thorax, abdomen and pelvis.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34415199      PMCID: PMC9327752          DOI: 10.1259/bjr.20210430

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.629


  27 in total

1.  Single-centre survey of the application of cardiovascular magnetic resonance in clinical routine.

Authors:  Florian von Knobelsdorff-Brenkenhoff; Angelika Bublak; Sana El-Mahmoud; Ralf Wassmuth; Christian Opitz; Jeanette Schulz-Menger
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2012-06-26       Impact factor: 6.875

2.  Computing inter-rater reliability and its variance in the presence of high agreement.

Authors:  Kilem Li Gwet
Journal:  Br J Math Stat Psychol       Date:  2008-05       Impact factor: 3.380

3.  MR angiography with an ultrasmall superparamagnetic iron oxide blood pool agent.

Authors:  Y Anzai; M R Prince; T L Chenevert; J H Maki; F Londy; M London; S J McLachlan
Journal:  J Magn Reson Imaging       Date:  1997 Jan-Feb       Impact factor: 4.813

4.  Wide, short bore magnetic resonance at 1.5 t: reducing the failure rate in claustrophobic patients.

Authors:  C H Hunt; C P Wood; J I Lane; B D Bolster; M A Bernstein; R J Witte
Journal:  Clin Neuroradiol       Date:  2011-05-20       Impact factor: 3.649

5.  Safety of Off-Label Use of Ferumoxtyol as a Contrast Agent for MRI: A Systematic Review and Meta-Analysis of Adverse Events.

Authors:  Faraz Ahmad; Lee Treanor; Trevor A McGrath; Daniel Walker; Matthew D F McInnes; Nicola Schieda
Journal:  J Magn Reson Imaging       Date:  2020-10-24       Impact factor: 4.813

6.  Contrast-enhanced breast MR imaging of claustrophobic or oversized patients using an open low-field magnet.

Authors:  M Calabrese; D Brizzi; L Carbonaro; M Chiaramondia; M A Kirchin; F Sardanelli
Journal:  Radiol Med       Date:  2009-02-04       Impact factor: 3.469

7.  Ferumoxytol-enhanced MR Angiography for Vascular Access Mapping before Transcatheter Aortic Valve Replacement in Patients with Renal Impairment: A Step Toward Patient-specific Care.

Authors:  Kim-Lien Nguyen; John M Moriarty; Adam N Plotnik; Olcay Aksoy; Takegawa Yoshida; Richard J Shemin; William M Suh; J Paul Finn
Journal:  Radiology       Date:  2017-10-16       Impact factor: 11.105

8.  High resolution, 3-dimensional Ferumoxytol-enhanced cardiovascular magnetic resonance venography in central venous occlusion.

Authors:  Puja Shahrouki; John M Moriarty; Sarah N Khan; Biraj Bista; Stephen T Kee; Brian G DeRubertis; Takegawa Yoshida; Kim-Lien Nguyen; J Paul Finn
Journal:  J Cardiovasc Magn Reson       Date:  2019-03-11       Impact factor: 5.364

9.  Effect of team training on patients' ability to complete MRI examinations.

Authors:  Elvira V Lang; Cayte Ward; Eleanor Laser
Journal:  Acad Radiol       Date:  2009-09-05       Impact factor: 3.173

10.  High-field MR imaging in pediatric congenital heart disease: initial results.

Authors:  Kim-Lien Nguyen; Sarah N Khan; John M Moriarty; Kiyarash Mohajer; Pierangelo Renella; Gary Satou; Ihab Ayad; Swati Patel; M Ines Boechat; J Paul Finn
Journal:  Pediatr Radiol       Date:  2014-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.